Apogenix GmbH
Develops innovative immunotherapeutics for cancer and viral infections, focusing on drug candidates that target TNFSF-dependent signaling pathways to improve immune responses and reduce inflammation.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
